clinics and supports sponsors with trial design optimization. Its digital twin technology predicts individual disease trajectories, quantifies patient heterogeneity, and helps reduce sample sizes while maintaining statistical power. Offerings target pharmaceutical companies, clinical research organizations, and academic investigators running neurological clinical trials.